Ares Capital Co. (NASDAQ:ARCC – Get Free Report)’s stock price hit a new 52-week high during trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $23.00 to $24.50. JPMorgan Chase & Co. currently has an overweight rating on the stock. Ares Capital traded as high as $23.77 and last traded at $23.76, with a volume of 3786340 shares trading hands. The stock had previously closed at $23.67.
ARCC has been the topic of several other research reports. Wells Fargo & Company lifted their target price on Ares Capital from $23.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, January 29th. B. Riley lifted their price objective on shares of Ares Capital from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Finally, StockNews.com upgraded shares of Ares Capital from a “sell” rating to a “hold” rating in a research report on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.79.
View Our Latest Research Report on Ares Capital
Institutional Investors Weigh In On Ares Capital
Ares Capital Stock Up 0.5 %
The firm has a market capitalization of $15.38 billion, a price-to-earnings ratio of 9.15 and a beta of 1.00. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.06. The stock has a fifty day moving average of $22.32 and a 200-day moving average of $21.47.
About Ares Capital
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.
Recommended Stories
- Five stocks we like better than Ares Capital
- How to Invest in Biotech Stocks
- How to Invest in Small Cap Stocks
- About the Markup Calculator
- These Are the Dividend Stocks Insiders Bought in January
- How to Plot Fibonacci Price Inflection Levels
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Ares Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Capital and related companies with MarketBeat.com's FREE daily email newsletter.